How to Interpret Data from the Superficial Femoral Artery Stenting Trials and Registries
Authors:
- Peter H. LinPLPeter H. Lin
- Sarah M. WeakleySWSarah M. Weakley
- Panagiotis KougiasPKPanagiotis Kougias
- 30 September 2010
- journal article
- review article
- Published by Elsevier in Seminars in Vascular Surgery
- Vol. 23 (3) , 138-147
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- TASC II and the Endovascular Management of Infrainguinal DiseaseJournal of Endovascular Therapy, 2009
- Evolving Modalities for Femoropopliteal InterventionsJournal of Endovascular Therapy, 2009
- Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)European Journal of Vascular and Endovascular Surgery, 2007
- Contemporary Endovascular Treatment for Disease of the Superficial Femoral and Popliteal Arteries: An Integrated Device-Based StrategyJournal of Endovascular Therapy, 2006
- Limitations of Percutaneous Transluminal Angioplasty and Stenting for the Treatment of Disease of the Superficial Femoral and Popliteal ArteriesJournal of Endovascular Therapy, 2006
- Procedural and Clinical Outcomes With Catheter-Based Plaque Excision in Critical Limb IschemiaJournal of Endovascular Therapy, 2006
- Stenting in the Femoropopliteal Arterial SegmentTechniques in Vascular and Interventional Radiology, 2005
- Long-Segment SFA Stenting—The Dark Sides: In-Stent Restenosis, Clinical Deterioration, and Stent FracturesJournal of Endovascular Therapy, 2005
- Saphenous Vein Versus PTFE for Above-Knee Femoropopliteal Bypass. A Review of the LiteratureEuropean Journal of Vascular and Endovascular Surgery, 2004
- Inflammatory Response to Stent Implantation: Differences in Femoropopliteal, Iliac, and Carotid ArteriesRadiology, 2002